AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Exosomes from plasmacytoma cells show promise as a tumor vaccine.
"Exosomes are membrane-bound vesicles derived from multivesicular bodies that are externalized by cells through fusion with the plasma membrane. Exosomes have been implicated in cell-to-cell signaling, and those derived from immunologic cells may be involved in both direct and cross-presentation of antigens to T cells. The research presented here evaluated their efficacy as a prophylactic cancer vaccine in a mouse plasmacytoma model," scientists in the United States report.
"Plasmacytoma cells were shown to release exosomes in vitro, and vaccination with a single dose (5 microgram) of exosome protein protected 80% of mice against challenge with wild-type tumors," stated Stephen L. Altieri and colleagues at the Roswell Park Cancer Institute. "Protection could be linked to the immune system since vaccinated mice generated specific cytotoxic T lymphocytes, the effects were not seen in SCID mice, and immunity was tumor-specific. Several proteins involved in immunity, including two potential tumor antigens (PIA and intracisternal A particle protein) as ...
Source: HighBeam Research, Exosomes from plasmacytoma cells show promise as tumor vaccine.